These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7877851)
1. Trypanosoma cruzi infection in mice enhances the membrane expression of low-affinity Fc receptors for IgG and the release of their soluble forms. Caraujo-Jorge T; el Bouhdidi A; Rivera MT; Daëron M; Carlier Y; Jorge TA [corrected to Caraujo-Jorge T] Parasite Immunol; 1993 Sep; 15(9):539-46. PubMed ID: 7877851 [TBL] [Abstract][Full Text] [Related]
2. An Fc gamma RII-, Fc gamma RIII-specific monoclonal antibody (2.4G2) decreases acute Trypanosoma cruzi infection in mice. Araujo-Jorge T; Rivera MT; el Bouhdidi A; Daëron M; Carlier Y Infect Immun; 1993 Nov; 61(11):4925-8. PubMed ID: 8406898 [TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection. Curotto de Lafaille MA; Barbosa de Oliveira LC; Lima GC; Abrahamsohn IA Exp Parasitol; 1990 Feb; 70(2):164-74. PubMed ID: 2105229 [TBL] [Abstract][Full Text] [Related]
4. Defective Fc gamma RII gene expression in macrophages of NOD mice: genetic linkage with up-regulation of IgG1 and IgG2b in serum. Luan JJ; Monteiro RC; Sautès C; Fluteau G; Eloy L; Fridman WH; Bach JF; Garchon HJ J Immunol; 1996 Nov; 157(10):4707-16. PubMed ID: 8906852 [TBL] [Abstract][Full Text] [Related]
5. Pregnancy and humoral immune response in mice chronically infected by Trypanosoma cruzi. Carlier Y; Rivera MT; Truyens C; Goldman M; Lambert P; Flament J; Bauwens D; Vray B Infect Immun; 1987 Oct; 55(10):2496-501. PubMed ID: 3115899 [TBL] [Abstract][Full Text] [Related]
6. IFN-gamma, IL-4, IL-10 and IL-12 gene expression in BCG-Leishmania vaccination of Trypanosoma cruzi-infected mice. Araujo Z; Heremans H; Stordeur P; Wissing M; Goldman M; Castes M; Carlier Y Vaccine; 2000 Mar; 18(17):1822-9. PubMed ID: 10699330 [TBL] [Abstract][Full Text] [Related]
7. Anti-Ia treatment modulates specific and polyclonal antibody responses in Trypanosoma cruzi-infected mice. Spinella S; Liegeard P; Guilbert B; Hontebeyrie-Joskowicz M J Autoimmun; 1989 Dec; 2(6):791-802. PubMed ID: 2515867 [TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies. Bermejo DA; Amezcua Vesely MC; Khan M; Acosta Rodríguez EV; Montes CL; Merino MC; Toellner KM; Mohr E; Taylor D; Cunningham AF; Gruppi A Immunology; 2011 Jan; 132(1):123-33. PubMed ID: 20875075 [TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinaemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies. el Bouhdidi A; Truyens C; Rivera MT; Bazin H; Carlier Y Parasite Immunol; 1994 Feb; 16(2):69-76. PubMed ID: 8015857 [TBL] [Abstract][Full Text] [Related]
10. Vaccination of mice with a combination of BCG and killed Leishmania promastigotes reduces acute Trypanosoma cruzi infection by promoting an IFN-gamma response. Araujo Z; El Bouhdidi A; Heremans H; Van Marck E; Castés M; Carlier Y Vaccine; 1999 Feb; 17(7-8):957-64. PubMed ID: 10067703 [TBL] [Abstract][Full Text] [Related]
11. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections. Antúnez MI; Cardoni RL Immunol Lett; 2001 Dec; 79(3):189-96. PubMed ID: 11600197 [TBL] [Abstract][Full Text] [Related]
12. Increased expression and secretion of ICAM-1 during experimental infection with Trypanosoma cruzi. Laucella S; Salcedo R; Castaños-Velez E; Riarte A; De Titto EH; Patarroyo M; Orn A; Rottenberg ME Parasite Immunol; 1996 May; 18(5):227-39. PubMed ID: 9229375 [TBL] [Abstract][Full Text] [Related]
13. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis. Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710 [TBL] [Abstract][Full Text] [Related]
14. Organ-specific regulation of interferon-gamma, interleukin-2 and interleukin-2 receptor during murine infection with Trypanosoma cruzi. Rottenberg ME; Sunnemark D; Leandersson T; Orn A Scand J Immunol; 1993 May; 37(5):559-68. PubMed ID: 8484102 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of anti-Trypanosoma cruzi serum obtained in acute and chronic phase of infection in mice. Takehara HA; Da Silva AM; Brodskyn CI; Mota I Immunol Lett; 1989 Dec; 23(2):81-5. PubMed ID: 2517266 [TBL] [Abstract][Full Text] [Related]
17. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites. Pérez Brandán C; Mesías AC; Parodi C; Cimino RO; Pérez Brandán C; Diosque P; Basombrío MÁ BMC Infect Dis; 2017 Nov; 17(1):732. PubMed ID: 29178839 [TBL] [Abstract][Full Text] [Related]
18. Alpha-2-macroglobulin receptor is differently expressed in peritoneal macrophages from C3H and C57/B16 mice and up-regulated during Trypanosoma cruzi infection. Coutinho CM; Cavalcanti G; DaMatta RA; Van Leuven F; Araújo-Jorge TC Tissue Cell; 1998 Aug; 30(4):407-15. PubMed ID: 9787474 [TBL] [Abstract][Full Text] [Related]
19. Acute and chronic experimental Trypanosoma cruzi infection in the rat. Response to systemic treatment with recombinant rat interferon-gamma. Revelli S; Davila H; Ferro ME; Romero-Piffiguer M; Musso O; Valenti J; Bernabo J; Falcoff E; Wietzerbin J; Bottasso O Microbiol Immunol; 1995; 39(4):275-81. PubMed ID: 7651241 [TBL] [Abstract][Full Text] [Related]
20. [TH1 response in the experimental infection with Trypanosoma cruzi]. Cardoni RL; Antúnez MI; Abrami AA Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]